<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title><![CDATA[ProZyme, Inc. and BiOptic Inc. 보도자료 - 뉴스와이어]]></title><link>https://www.newswire.co.kr/?md=A10&amp;act=article&amp;no=25698></link><description><![CDATA[ProZyme, Inc. and BiOptic Inc. 보도자료 - 뉴스와이어 RSS 서비스]]></description><lastBuildDate>Thu, 14 May 2026 05:25:15 +0900</lastBuildDate><copyright>Copyright (c) 2004~2026 Korea Newswire All rights reserved</copyright><image><url><![CDATA[https://file.newswire.co.kr/data/upfile/company_img/2015/09/3554153577_20150918112047_5227938757.jpg]]></url></image><language>ko-KR</language><item><title><![CDATA[ProZyme, Inc. and BiOptic, Inc. Sign Licensing Agreement to Develop Gly-Q System for Glycan Analysis]]></title><link>https://www.newswire.co.kr/newsRead.php?no=803967</link><description><![CDATA[HAYWARD, Calif.--(Business Wire/Korea Newswire)--ProZyme, Inc., manufacturer of bioreagents for glycobiology, and BiOptic Inc. of Taiwan, manufacturer of instruments for DNA analysis by capillary gel electrophoresis (CGE), today announce an agreement to collaborate on the development and commercialization of an integrated system (Gly-Q™) for high-throughput, user-friendly glycoanalysis. The Gl...]]></description><pubDate>Fri, 18 Sep 2015 11:30:00 +0900</pubDate></item><item><title><![CDATA[프로자임과 바이옵틱, 글리칸 분석 용 ‘Gly-Q’시스템 개발을 위한 라이센싱 계약 체결]]></title><link>https://www.newswire.co.kr/newsRead.php?no=803969</link><description><![CDATA[헤이워드, 캘리포니아--(Business Wire/뉴스와이어)--당 생물학(glycobiology) 용 바이오 시약 제조업체인 프로자임(ProZyme, Inc.)과 대만의 모세혈관 젤 전기영동법(capillary gel electrophoresis[CGE]) 기반DNA분석 장비 업체인 바이옵틱(BiOptic Inc.)이 처리율이 높은 사용자 친화적 당분석을 위한 통합 시스템(Gly-Q™)의 개발 및 상용화를 위한 협력 계약을 체결했다고 오늘 발표했다. 프로자임은 ‘Gly-Q’ 시스템 개발 ...]]></description><pubDate>Fri, 18 Sep 2015 11:30:00 +0900</pubDate></item></channel></rss>